Cancer Stem Cells and Glioblastoma: Time for Innovative Biomarkers of Radio-Resistance?

7Citations
Citations of this article
18Readers
Mendeley users who have this article in their library.

Abstract

Despite countless papers in the field of radioresistance, researchers are still far from clearly understanding the mechanisms triggered in glioblastoma. Cancer stem cells (CSC) are important to the growth and spread of cancer, according to many studies. In addition, more recently, it has been suggested that CSCs have an impact on glioblastoma patients’ prognosis, tumor aggressiveness, and treatment outcomes. In reviewing this new area of biology, we will provide a summary of the most recent research on CSCs and their role in the response to radio-chemotherapy in GB. In this review, we will examine the radiosensitivity of stem cells. Moreover, we summarize the current knowledge of the biomarkers of stemness and evaluate their potential function in the study of radiosensitivity.

Cite

CITATION STYLE

APA

Pasqualetti, F., Miniati, M., Gonnelli, A., Gadducci, G., Giannini, N., Palagini, L., … Paiar, F. (2023, October 1). Cancer Stem Cells and Glioblastoma: Time for Innovative Biomarkers of Radio-Resistance? Biology. Multidisciplinary Digital Publishing Institute (MDPI). https://doi.org/10.3390/biology12101295

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free